Clinical Trials Logo

Clinical Trial Summary

Studying the effects of Etanercept (an anti-Tumor Necrosis Factor alpha) on early Chronic Regional Pain Syndrome (CRPS). Our hypothesis is that Etanercept will improve patient symptoms if given in early CRPS.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02031211
Study type Interventional
Source Stanford University
Contact
Status Withdrawn
Phase N/A
Start date June 2014
Completion date October 2016

See also
  Status Clinical Trial Phase
Recruiting NCT00377468 - Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study) Phase 2
Completed NCT01618578 - The Rubber Hand Illusion (RHI) in Patients With CRPS N/A
Completed NCT02467556 - Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome Phase 4
Recruiting NCT01601925 - Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block N/A
Withdrawn NCT04709757 - Comparison of Continuous and Burst High Frequency Spinal Cord Stimulation Paradigms N/A
Completed NCT00558753 - Prospective, Randomized Controlled Trial on Perioperative Pregabalin to Reduce Late-onset CRPS After TKA Phase 2
Active, not recruiting NCT05473338 - Complex Regional Pain Syndrome (CRPS) and the Gut-bacteria